Organization of workshops, events and training courses for medical staff, to understand, learn and broaden their knowledge.
Research and development are the primary objective of Marllor Biomedichal. The major investments are focused on clinical studies, quality and device registration. The research is oriented in three fundamental directions:
Scientific research and medical training are entrusted to an international scientific board of the highest level.
Marllor Biomedichal is launching new products by integrating regulatory issues into all of its R&D activities from start to finish. The company has the total exclusive sale of Aqualyx®, the only device in the world indicated for the treatment of localized adiposity.
Our communication policy is to maintain a coordinated image starting from the graphic aspects of the brands up to communication via the institutional website, social network, e-commerce and presence in various congresses of Medicine and Aesthetic Surgery.
A division dedicated to the edition of books and magazines in the field of medical-surgical sciences related to improving the quality of life and aesthetics, as well as the treatment and prevention of aging.
EJAMeD, International Journal of Aesthetic Medicine and Dermatology is the magazine that has been talking about aesthetic medicine and dermatology since 2011.
Marllor Biomedical has also published two books dedicated to aesthetic medicine in Italian:
